Czechia - Immunosuppressants - TNF alpha inhibitors Infliximab s.c. administration II

different companies won its awards

140

of the awards went to the three most frequent winners

11%

of its calls state an estimated value

100%

Based on 250 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

1.5

of those lots received a single tender

56%

of the awards went to companies based in another country

1%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Czechia · Medical equipment & pharmaceuticals

different companies won awards here

1,142

of the awards went to the three most frequent winners

19%

buyers awarded contracts here

173

Based on 4,913 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

1.6

of those lots received a single tender

61%

of the awards went to companies based in another country

1%

of the tenders came from another country

1%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.